ASND
Ascendis Pharma A/S
NASDAQ · Healthcare · Biotechnology · DK
$270.56
−0.21%Forward multiples
Based on analyst estimates
- P/E forward
- 37.31x
- P/E 2026E
- 16.04x
- P/E 2027E
- 25.20x
- P/E 2028E
- 15.90x
- P/S forward
- 8.90x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.23x
- PEG TTM
- —
- Price / book
- 10.63x
- Price / sales
- 14.48x
- Price / cash flow
- 43.45x
Enterprise value
- Enterprise value
- $17.3B
- EV / sales
- 14.14x
- EV / EBITDA
- 190.77x
- EV / EBIT
- 136.17x
- Market cap
- $17.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026